Abstract:Abstract Defining off-target profiles of gene-editing nucleases and CRISPR base editors remains an important challenge for use of these technologies, therapeutic or otherwise. Existing methods can identify off-target sites induced by these gene editors on an individual genome but are not designed to account for the broad diversity of genomic sequence variation that exists within populations of humans or other organisms. Here we describe OligoNucleotide Enrichment and sequencing ( ONE-seq ), a novel in vitro method that leverages customizable, high-throughput DNA synthesis technology instead of purified genomic DNA ( gDNA ) from individual genomes to profile gene editor off-target sites. We show that ONE-seq matches or exceeds the sensitivity of existing single-genome methods for identifying bona fide CRISPR-Cas9 off-target sites in cultured human cells and in vivo in a liver-humanized mouse model. In addition, ONE-seq outperforms existing best-in-class single-genome methods for defining off-target sites of CRISPR-Cas12a nucleases, cytosine base editors ( CBE s), and adenine base editors ( ABE s), unveiling previously undescribed bona fide off-target sites for all these editors in human cells. Most importantly, we leveraged ONE-seq to generate the first experimentally-derived population-scale off-target profiles for Cas9 nucleases that define the impacts of sequence variants from >2,500 individual human genome sequences in the 1000 Genomes Project database. Notably, some of the variants we identified that lead to increased mutation frequencies at off-target sites are enriched in specific human populations. We validated that novel population-specific, variant-sensitive off-target sites nominated by ONE-seq in vitro can show increased frequencies of mutations in human lymphoblastoid cells ( LCL s) harboring these sequence variants. Collectively, our results demonstrate that ONE-seq is a highly sensitive off-target nomination method that can uniquely be used to identify population subgroup-linked differences in off-target profiles of gene editors. ONE-seq provides an important new pathway by which to assess the impacts of global human genetic sequence diversity on the specificities of gene editors, thereby enabling a broader and more all-inclusive approach for profiling off-target effects of these transformative therapeutic technologies.

Whole genome analysis for 163 gRNAs in Cas9-edited mice reveals minimal off-target activity

CRISPR/Cas9 Targeting Events Cause Complex Deletions and Insertions at 17 Sites in the Mouse Genome

Potential high-frequency off-target mutagenesis induced by CRISPR/Cas9 in Arabidopsis and its prevention

Potential high-frequency off-target mutagenesis induced by CRISPR/Cas9 in <i>Arabidopsis</i> and its prevention

Trio deep-sequencing does not reveal unexpected mutations in Cas9-edited monkeys

Genome-Wide Analysis of Off-Target CRISPR/Cas9 Activity in Single-Cell-Derived Human Hematopoietic Stem and Progenitor Cell Clones

Global-scale CRISPR gene editor specificity profiling by ONE-seq identifies population-specific, variant off-target effects

Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases

Human genetic diversity alters off-target outcomes of therapeutic gene editing

Off-target Effects in CRISPR/Cas9-mediated Genome Engineering

Novel off-Targeting Events Identified after Genome Wide Analysis of CRISPR-Cas Edited Pigs

Genome editing with natural and engineered CjCas9 orthologs

Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq

Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity

Whole genomic analysis reveals atypical non-homologous off-target large structural variants induced by CRISPR-Cas9-mediated genome editing

A Large-Scale Whole-Genome Sequencing Analysis Reveals Highly Specific Genome Editing by Both Cas9 and Cpf1 (cas12a) Nucleases in Rice

Enhanced in vivo gene knockout with undetectable off-targets using multiplexed Cas12a sgRNAs

Genome-wide Binding of the CRISPR Endonuclease Cas9 in Mammalian Cells

CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences

CRISPR-Cas9 Editing in Maize: Systematic Evaluation of Off-target Activity and Its Relevance in Crop Improvement